QBIC III Fund
Overview
QBIC III is an early-stage venture capital fund managed by Qbic Fund that invests in spin-offs from multiple partner institutes, focusing on deeptech, software, biotech, and medtech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AmphiStar | Apr 2024 | Seed | Co-investor |
| Animab | Jul 2025 | Series B | Lead |
| Pleevi | Jan 2025 | Seed | Co-investor |
| THERAtRAME | Sep 2022 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is QBIC III Fund based?
QBIC III Fund is headquartered in Belgium.
When was QBIC III Fund founded?
QBIC III Fund was founded in 2022.
How many portfolio companies does QBIC III Fund have?
QBIC III Fund has 4 portfolio companies in Caplight's dataset.
What are some companies in QBIC III Fund's portfolio?
Portfolio companies visible on Caplight include AmphiStar, Animab, Pleevi, THERAtRAME.
What was QBIC III Fund's most recent investment shown here?
QBIC III Fund's most recent investment in this portfolio sample was in Animab in 2025.
What sectors does QBIC III Fund focus on?
QBIC III Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Mobility, Transportation & Logistics, Healthcare & Life Sciences.
What company stages does QBIC III Fund focus on?
QBIC III Fund typically invests at the Early stage.
What is QBIC III Fund's AUM?
QBIC III Fund's assets under management are estimated between $205.2M and $216.0M.